Raheleh Farahzadi
Tabriz University of Medical Sciences, Australia · Iran, Islamic Republic of
Editorial leadership for Journal of In-vitro In-vivo In-silico Journal
Biography
Raheleh Farahzadi is affiliated with Tabriz University of Medical Sciences, Australia, and has contributed extensively to regenerative medicine and stem cell research. Her work encompasses the isolation, characterization, and therapeutic application of mesenchymal stem cells derived from adipose tissue and amniotic fluid, with particular emphasis on aging mechanisms, telomere activity, and differentiation pathways. She has investigated novel interventions including growth factor delivery systems for myocardial infarction, the effects of L-carnitine on stem cell aging and gene expression, and the influence of electromagnetic fields on cellular processes. Her most-cited publication, "COVID-19 infection: an overview on cytokine storm and related interventions" (2022), has received 540 citations, and she has authored 14 or more indexed publications spanning translational and veterinary medicine.
Selected publications
- COVID-19 infection: an overview on cytokine storm and related interventions 2022 cited 540×
- Cytokines secreted from bone marrow derived mesenchymal stem cells promote apoptosis and change cell cycle distribution of K562 cell line as clinical agent in cell transplantation 2019 cited 56×
- Silver nanoparticles induce the cardiomyogenic differentiation of bone marrow derived mesenchymal stem cells via telomere length extension 2021 cited 50×
- Granulocyte differentiation of rat bone marrow resident C-kit+ hematopoietic stem cells induced by mesenchymal stem cells could be considered as new option in cell-based therapy 2023 cited 45×
- Cardiac differentiation of bone-marrow-resident c-kit+ stem cells by L-carnitine increases through secretion of VEGF, IL6, IGF-1, and TGF-β as clinical agents in cardiac regeneration 2020 cited 43×
- Interleukin-6, -8, and TGF-β Secreted from Mesenchymal Stem Cells Show Functional Role in Reduction of Telomerase Activity of Leukemia Cell Via Wnt5a/β-Catenin and P53 Pathways 2020 cited 39×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IIIJ for your work?
This journal is guided by Raheleh Farahzadi (Tabriz University of Medical Sciences, Australia) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.